Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Lupin Ltd is up for a fifth straight session today. The stock is quoting at Rs 1989.8, up 0.51% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.11% on the day, quoting at 25000.8. The Sensex is at 81517.52, up 0.11%. Lupin Ltd has gained around 2.37% in last one month.
Meanwhile, Nifty Pharma index of which Lupin Ltd is a constituent, has gained around 2.16% in last one month and is currently quoting at 22122.05, up 0.46% on the day. The volume in the stock stood at 3.89 lakh shares today, compared to the daily average of 6.58 lakh shares in last one month.
The benchmark September futures contract for the stock is quoting at Rs 2000, up 0.61% on the day. Lupin Ltd is down 11.47% in last one year as compared to a 1.53% slide in NIFTY and a 5.15% slide in the Nifty Pharma index.
The PE of the stock is 17.13 based on TTM earnings ending June 25.
The company further stated that the said inspection closed with two observations.
“We will address the observations and respond to the United States Food and Drug Administration (U.S. FDA) within the stipulated timeframe. We are committed to be compliant with CGMP quality standards across all our facilities,” Lupin said in a statement.
Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.
The company's consolidated net profit jumped 52.13% to Rs 1,219.03 crore on 11.78% increase in income from operations to Rs 6,163.75 crore in Q1 FY26 over Q1 FY25.
The scrip had gained 0.27% to end at Rs 1944.65 on the BSE on Friday.